| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |